Skip to main content

Institute for Bioengineering of Catalonia (IBEC)

ApplicationBarcelona, SpainFounded 2008· One of 313 Application companies tracked by AMPulse

Conducts interdisciplinary research in bioengineering, focusing on nanomedicine and tissue engineering applications.

CEO / Founder
Manuel Salmeron
Team Size
201-500
Stage
Active
Total Funding
$28.2M
Latest Round
Grant - $4.8M - 2023-01
Key Investors
Founding Institutions: Generalitat de Catalunya, University of Barcelona, Polytechnic University of Catalonia

Technology & Products

Key Products

MicrofabSpace Facility (micro/nanofabrication services); Nanotechnology Platform; Bioengineering research services; Organs-on-a-chip development; Bioprinting of functional tissues; Nanobots for drug delivery

Technological Advantage

Positioned as a global hub for bioengineering in Catalonia, coordinating the Spanish Nanomedicine Platform to bridge research and industry.

Differentiation

Value Proposition

Advances healthcare through interdisciplinary bioengineering research and public-private collaboration in nanomedicine and tissue engineering.

How They Differentiate

Integrates nanomedicine with bioprinting and organs-on-a-chip; holds 'Severo Ochoa Centre of Excellence' status (top 1% of Spanish research); operates the MicrofabSpace, a 150m2 Class 10,000 cleanroom for specialized micro/nanodevice fabrication and characterization

Market & Competition

Target Customers

Pharmaceutical companies seeking advanced drug testing models; Medical device manufacturers; Academic research institutions; Healthcare providers for regenerative medicine applications

Industry Verticals

Medical; Healthcare; Nanomedicine

Competitors

Wyss Institute; Terasaki Institute; Wake Forest Institute for Regenerative Medicine (WFIRM)

Growth & Milestones

Growth Metrics

23 research groups; 395 researchers and staff from 38 countries.

Major Milestones

Leadership transition to Manuel Salmerón as interim director; Executive coordinator of Spanish Nanomedicine Platform since 2016; 2024 PCB expansion plans including IBEC HQ

Notable Customers

European Molecular Biology Laboratory (EMBL); Barcelona Institute of Science and Technology (BIST); Hospital Clínic de Barcelona; University of Barcelona; Technical University of Catalonia (UPC)